Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo, 060-0812, Japan.
J Antibiot (Tokyo). 2019 Dec;72(12):924-933. doi: 10.1038/s41429-019-0200-1. Epub 2019 Jun 25.
Tunicamycins are nucleoside natural products and show antibacterial, antiviral and antitumor activities, which are attributed to their inhibition of enzymatic reactions between polyisoprenyl phosphate and UDP-GlcNAc or UDP-MurNAc-pentapeptide. Because of their various intriguing biological activities, tunicamycins have potential as therapeutic agents for infectious diseases or cancers. Structurally, tunicamycins have a unique structure composed of an undecodialdose skeleton, a lipid chain and a GlcNAc fragment linked by a 1,1-β,α-trehalose-type glycosidic bond. In this mini review, we summarize the total chemical syntheses and biosynthetic studies of tunicamycins.
束丝霉素是核苷类天然产物,具有抗菌、抗病毒和抗肿瘤活性,这归因于它们抑制多异戊烯磷酸与 UDP-GlcNAc 或 UDP-MurNAc-五肽之间的酶反应。由于其各种有趣的生物活性,束丝霉素有望成为治疗传染病或癌症的药物。在结构上,束丝霉素具有独特的结构,由十一烷骨架、脂质链和通过 1,1-β,α-海藻糖型糖苷键连接的 GlcNAc 片段组成。在这篇综述中,我们总结了束丝霉素的全合成化学和生物合成研究。